Highly innovative gas microsensors, the result of fifteen years' research in the UCLouvain laboratories, will soon be on the market thanks to Belgian investors.
The first malaria vaccine, tested in three African countries after being designed and produced in Belgium, will be available to all children as recommended by the World Health Organization (WHO).
An alliance between two leading Belgian players in the fight against cancer means that the production of a very promising drug can be envisaged in the near future.